Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07805512) titled 'A Study to Evaluate the Effectiveness and Safety of Restylane Shaype in the Improvement of Jawline Definition' on Sept. 1.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).

Primary Sponsor: Galderma R&D

Condition: Jawline Definition

Intervention: Device: Restylane Shaype

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: September 2026

Target Sample Size: 162

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07805512

Discl...